BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
 | 
Oct 29, 2009
 |  BC Extra  |  Company News

Amicus, Shire end deal

Amicus Therapeutics Inc. (NASDAQ:FOLD) said late Thursday that it and Shire plc (LSE:SHP; NASDAQ:SHPGY) mutually ended a 2007 deal to develop Amicus' Amigal migalastat, Plicera afegostat tartrate and AT2220 deoxynojirimycin. Amicus regains all rights to the compounds and will receive a final $5.2 million payment from...

Read the full 234 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >